Vivanza Biosciences Ltd (530057) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 530057 | NSE: | Trading | Small Cap

Vivanza Biosciences Share Price

2.13 -0.01 -0.47%
as on 05-Dec'25 12:12

Vivanza Biosciences Ltd (530057) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 530057 | NSE: | Trading | Small Cap

DeciZen - make an informed investing decision on Vivanza Biosciences

Based on:

M-Cap below 100cr DeciZen not available

Vivanza Biosciences stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
8.6 Cr.
52-wk low:
1.9
52-wk high:
4

Is Vivanza Biosciences Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Vivanza Biosciences: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Vivanza Biosciences Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % -10.6%-4.9%14.3%-0.6%6.1%17.8%15.2%11.7%9%-3.8%-
Value Creation
Index
-1.8-1.40.0-1.1-0.60.30.1-0.2-0.4-1.3-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 03.56.42.29.49.29.214.214.42.962
Sales YoY Gr.-NA85.6%-65.5%322.1%-1.6%-0.8%55.3%1.4%-79.6%-
Adj EPS -0.3-00.1-0.1-0.100.10.20.1-0.2-0.1
YoY Gr.-NANA-283.3%NANA366.7%7.1%-46.7%-312.5%-
BVPS (₹) 0.10.910.90.80.811.11.211.1
Adj Net
Profit
-0.1-0.20.2-0.5-0.20.10.50.60.3-0.7-0
Cash Flow from Ops. -0.1-2-0.21.42.8-3.1-0.70.21.8-2.5-
Debt/CF from Ops. -10.9-0.3-4.70.70.1-0.1-6.540.81.8-2.5-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA-20.7%-31.5%-79.6%
Adj EPS NANA-206.7%-312.5%
BVPS25.6%4.3%1.7%-14.4%
Share Price -9.4% -18.3% -46% -39.8%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
-63.2-9.36.3-12.2-6.131514.37-15.8-10.3
Op. Profit
Mgn %
0-4.69.9-1.3-3.21.425.45.6-11.9-0.3
Net Profit
Mgn %
0-53.7-20.2-2.21.15.94.12.2-23.4-0.7
Debt to
Equity
20.30.10.20.30.10.11.21.50.71.50.2
Working Cap
Days
04185131,8654864414273944211,6601,524
Cash Conv.
Cycle
013711496-161316096103675301

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Vivanza Biosciences Ltd.

Standalone Consolidated
TTM EPS (₹) -0.1 -0.1
TTM Sales (₹ Cr.) 62.5 66.3
BVPS (₹.) 1.1 1.2
Reserves (₹ Cr.) 1 1
P/BV 1.90 1.86
PE 0.00 0.00
From the Market
52 Week Low / High (₹) 1.90 / 4.01
All Time Low / High (₹) 0.05 / 21.00
Market Cap (₹ Cr.) 8.6
Equity (₹ Cr.) 4
Face Value (₹) 1
Industry PE 36.9

Management X-Ray of Vivanza Biosciences:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Vivanza Biosciences - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Vivanza Biosciences

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales03.476.442.229.379.229.1514.2114.412.94
Operating Expenses 0.063.645.802.259.669.099.0713.4713.613.30
Manufacturing Costs00.020.0900.040.010.1000.030.01
Material Costs03.075.531.989.148.568.4812.9612.982.62
Employee Cost 00.260.060.020.100.110.080.220.310.36
Other Costs 0.060.280.130.250.390.410.410.290.280.31
Operating Profit -0.06-0.160.64-0.03-0.300.130.070.740.81-0.36
Operating Profit Margin (%) --4.6%9.9%-1.3%-3.2%1.4%0.8%5.2%5.6%-12.3%
Other Income 00.05000.530.500.830.390.050.03
Interest 00.040.370.420.440.470.430.430.420.35
Depreciation 000000.010.0100.010.01
Exceptional Items 0000000000
Profit Before Tax -0.06-0.160.27-0.45-0.200.150.460.690.43-0.69
Tax 000.03000.0500.120.110
Profit After Tax -0.06-0.160.24-0.45-0.200.100.460.570.32-0.70
PAT Margin (%) --4.6%3.7%-20.2%-2.2%1.1%5.1%4.0%2.2%-23.6%
Adjusted EPS (₹)-0.3-0.00.1-0.1-0.10.00.10.10.1-0.2
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 0.023.683.923.473.273.373.834.404.724.02
Share Capital 0.19444444444
Reserves -0.16-0.32-0.08-0.53-0.73-0.63-0.170.400.720.02
Minority Interest0000000000
Debt0.500.530.770.900.180.184.426.563.266.09
Long Term Debt000000000.780.78
Short Term Debt0.500.530.770.900.180.184.426.562.495.32
Trade Payables0.052.564.845.758.143.865.488.668.233.22
Others Liabilities 0.060.160.140.710.690.530.470.820.660.58
Total Liabilities 0.646.939.6610.8312.287.9314.2120.4416.8713.91

Fixed Assets

Gross Block000000.020.020.020.060.07
Accumulated Depreciation000000.010.020.020.030.05
Net Fixed Assets 000000.01000.030.02
CWIP 0000000000
Investments 01.911.911.911.911.911.911.911.911.91
Inventories01.812.281.910.850.402.231.611.801.84
Trade Receivables02.535.075.546.416.117.3512.1810.377.39
Cash Equivalents 0.03-2.33-3.02-3.03-2.81-3.110.020.100.090.05
Others Assets 0.603.013.414.505.922.612.694.622.672.70
Total Assets 0.646.939.6610.8312.287.9314.2120.4416.8713.91

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity -0.05-1.98-0.161.372.80-3.08-0.680.161.80-2.47
PBT -0.06-0.160.27-0.45-0.200.150.460.690.43-0.69
Adjustment 00.070.360.430.440.480.410.420.430.36
Changes in Working Capital 0.01-1.9-0.791.392.56-3.65-1.55-0.831.05-2.14
Tax Paid 00000-0.05-0-0.12-0.110
Cash Flow From Investing Activity 01.90000-0.0200-0.04-0.01
Capex 00000-0.0200-0.04-0.01
Net Investments 01.9000000000
Others 0000000000
Cash Flow From Financing Activity 0.02-2.28-0.53-1.38-2.582.800.65-0.08-1.772.44
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid 0-0.04-0.36-0.42-0.44-0.47-0.41-0.42-0.41-0.35
Dividend Paid 0000000000
Others 0.02-2.24-0.17-0.96-2.143.271.060.34-1.362.79
Net Cash Flow -0.02-2.36-0.69-0.010.22-0.30-0.030.09-0.01-0.04

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)-79.68-8.586.32-12.16-6.053.0112.8913.846.97-15.91
ROCE (%)-10.61-4.8814.33-0.636.0717.8315.1911.668.96-3.76
Asset Turnover Ratio00.920.780.220.820.910.830.820.770.19
PAT to CFO Conversion(x)N/AN/A-0.67N/AN/A-30.8-1.480.285.63N/A
Working Capital Days
Receivable Days02662158722312482692512861,101
Inventory Days01901163445425524943226
Payable Days0155244973277256201199237796

Vivanza Biosciences Ltd Stock News

Vivanza Biosciences Ltd FAQs

The current trading price of Vivanza Biosciences on 05-Dec-2025 12:12 is ₹2.13.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Vivanza Biosciences stood at ₹8.56.
The latest P/E ratio of Vivanza Biosciences as of 04-Dec-2025 is 0.00.
The latest P/B ratio of Vivanza Biosciences as of 04-Dec-2025 is 1.90.
The 52-week high of Vivanza Biosciences is ₹4.01 and the 52-week low is ₹1.90.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Vivanza Biosciences is ₹62.48 ( Cr.) .

About Vivanza Biosciences Ltd

Head quartered in Gujarat, Vivanza Biosciences Limited came into existence in April 2016 with the sole aim to further spread its wings in global market with global quality pharmaceutical products at competitive pricing system. It is the bridge between people, Medical Practitioners and the Patients and together it is a healthcare organization dedicated to improving the lives of people globally.

Business area of the company

The company is engaged in the business of business of Pharmaceutical Products.

Products

  • Gloves
  • Surgicals
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×